Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MDP Stock Alerts C$1.92 +0.06 (+3.23%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarnings Medexus Pharmaceuticals Stock Price Performance5 Day Performance+18.52%1 Month Performance+12.94%3 Month Performance-24.71%6 Month Performance-5.88%Year-To-Date Performance-22.27% Receive MDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. MDP Stock Chart for Saturday, April, 27, 2024 MDP Chart by TradingView Medexus Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024C$1.86C$1.92+3.23%C$1.92C$1.8032,538 shsC$46.96 million04/25/2024C$1.74C$1.86+6.90%C$1.90C$1.7547,421 shsC$45.50 million04/24/2024C$1.65C$1.74+5.45%C$1.83C$1.68143,076 shsC$42.56 million04/23/2024C$1.62C$1.65+1.85%C$1.69C$1.6327,608 shsC$40.36 million04/22/2024C$1.65C$1.62-1.82%C$1.68C$1.5557,642 shsC$39.63 million04/19/2024C$1.55C$1.65+6.45%C$1.70C$1.5274,660 shsC$40.36 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024C$1.51C$1.55+2.65%C$1.55C$1.4751,716 shsC$37.91 million04/17/2024C$1.54C$1.51-1.95%C$1.55C$1.5041,094 shsC$36.94 million04/16/2024C$1.56C$1.54-1.28%C$1.59C$1.5126,610 shsC$37.67 million04/15/2024C$1.58C$1.56-1.27%C$1.61C$1.5370,356 shsC$38.16 million04/12/2024C$1.56C$1.58+1.28%C$1.62C$1.5468,200 shsC$38.65 million04/11/2024C$1.56C$1.56C$1.62C$1.5349,920 shsC$38.16 million04/10/2024C$1.55C$1.56+0.65%C$1.60C$1.5175,360 shsC$38.16 million04/09/2024C$1.59C$1.55-2.52%C$1.61C$1.5253,549 shsC$37.91 million04/08/2024C$1.62C$1.59-1.85%C$1.66C$1.5442,785 shsC$38.89 million04/05/2024C$1.63C$1.62-0.61%C$1.66C$1.5652,443 shsC$39.63 million04/04/2024C$1.69C$1.63-3.55%C$1.71C$1.6260,908 shsC$39.87 million04/03/2024C$1.54C$1.69+9.74%C$1.72C$1.5532,058 shsC$41.34 million04/02/2024C$1.61C$1.54-4.35%C$1.60C$1.5240,624 shsC$37.67 million04/01/2024C$1.61C$1.61C$1.70C$1.5655,154 shsC$39.38 million03/29/2024C$1.61C$1.61C$1.72C$1.6032,600 shsC$39.38 million03/28/2024C$1.70C$1.61-5.29%C$1.72C$1.6032,582 shsC$39.38 million03/27/2024C$1.70C$1.70C$1.75C$1.6543,705 shsC$41.58 million03/26/2024C$1.52C$1.70+11.84%C$1.76C$1.5798,276 shsC$41.58 million03/25/2024C$1.56C$1.52-2.56%C$1.57C$1.5044,339 shsC$37.18 million03/22/2024C$1.54C$1.56+1.30%C$1.56C$1.5123,733 shsC$38.16 million03/21/2024C$1.56C$1.54-1.28%C$1.58C$1.5221,330 shsC$37.67 million03/20/2024C$1.52C$1.56+2.63%C$1.57C$1.5123,100 shsC$38.16 million03/19/2024C$1.54C$1.52-1.30%C$1.54C$1.4820,701 shsC$37.18 million03/18/2024C$1.54C$1.54C$1.59C$1.5428,559 shsC$37.67 million03/15/2024C$1.55C$1.54-0.65%C$1.60C$1.5332,039 shsC$37.67 million03/14/2024C$1.60C$1.55-3.13%C$1.60C$1.5541,673 shsC$37.91 million03/13/2024C$1.64C$1.60-2.44%C$1.68C$1.5536,430 shsC$39.14 million03/12/2024C$1.67C$1.64-1.80%C$1.73C$1.5651,151 shsC$40.11 million03/11/2024C$1.70C$1.67-1.76%C$1.72C$1.6727,870 shsC$40.85 million03/08/2024C$1.73C$1.70-1.73%C$1.74C$1.6928,300 shsC$41.58 million03/07/2024C$1.71C$1.73+1.17%C$1.77C$1.6934,800 shsC$42.32 million03/06/2024C$1.70C$1.71+0.59%C$1.74C$1.7026,960 shsC$41.83 million03/05/2024C$1.72C$1.70-1.16%C$1.71C$1.6942,150 shsC$41.58 million03/04/2024C$1.82C$1.72-5.49%C$1.81C$1.7118,450 shsC$42.07 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024C$1.77C$1.82+2.82%C$1.86C$1.7532,910 shsC$44.52 million02/29/2024C$1.80C$1.77-1.67%C$1.85C$1.7573,949 shsC$43.29 million02/28/2024C$1.79C$1.80+0.56%C$1.87C$1.7953,887 shsC$44.03 million02/27/2024C$1.75C$1.79+2.29%C$1.80C$1.7535,972 shsC$43.78 million02/26/2024C$1.70C$1.75+2.94%C$1.77C$1.6950,560 shsC$42.81 million02/23/2024C$1.69C$1.70+0.59%C$1.73C$1.6419,430 shsC$41.58 million02/22/2024C$1.75C$1.69-3.43%C$1.77C$1.6716,460 shsC$41.34 million02/21/2024C$1.64C$1.75+6.71%C$1.76C$1.6047,001 shsC$42.81 million02/20/2024C$1.75C$1.64-6.29%C$1.75C$1.6426,466 shsC$40.11 million02/19/2024C$1.75C$1.75C$1.80C$1.7031,926 shsC$42.81 million02/16/2024C$1.79C$1.75-2.23%C$1.80C$1.7031,926 shsC$42.81 million02/15/2024C$1.78C$1.79+0.56%C$1.87C$1.7842,300 shsC$43.78 million02/14/2024C$1.67C$1.78+6.59%C$1.90C$1.6762,408 shsC$43.54 million02/13/2024C$1.79C$1.67-6.70%C$1.78C$1.6648,575 shsC$40.85 million02/12/2024C$1.87C$1.79-4.28%C$2.00C$1.71149,105 shsC$43.78 million02/09/2024C$1.92C$1.87-2.60%C$1.89C$1.66201,280 shsC$45.74 million02/08/2024C$2.70C$1.92-28.89%C$2.35C$1.75417,042 shsC$46.96 million02/07/2024C$2.67C$2.70+1.12%C$2.84C$2.6649,409 shsC$66.04 million02/06/2024C$2.58C$2.67+3.49%C$2.68C$2.5424,905 shsC$65.31 million02/05/2024C$2.45C$2.58+5.31%C$2.58C$2.4134,485 shsC$63.11 million02/02/2024C$2.34C$2.45+4.70%C$2.52C$2.3254,464 shsC$59.93 million02/01/2024C$2.32C$2.34+0.86%C$2.39C$2.3131,402 shsC$57.24 million01/31/2024C$2.36C$2.32-1.69%C$2.40C$2.2854,775 shsC$56.75 million01/30/2024C$2.49C$2.36-5.22%C$2.50C$2.3567,159 shsC$57.73 million01/29/2024C$2.55C$2.49-2.35%C$2.58C$2.4831,084 shsC$60.91 million01/26/2024C$2.54C$2.55+0.39%C$2.59C$2.5032,910 shsC$62.37 million Related Companies: Charlotte's Web Stock Chart MediPharm Labs Stock Chart Decibel Cannabis Stock Chart Indiva Stock Chart Willow Biosciences Stock Chart Valeo Pharma Stock Chart Medicure Stock Chart BioSyent Stock Chart HLS Therapeutics Stock Chart Theralase Technologies Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.